RECURRENT GLIOSARCOMA

Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GLIOSARCOMA trials appear

Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2

Scientists test 'Tiny Warhead' therapy to target deadly recurrent brain tumors

Disease control Not yet recruiting

This early-stage study is testing a new two-drug combination for glioblastoma, an aggressive brain cancer that has returned after initial treatment. The first drug is a radioactive antibody designed to find and deliver radiation directly to cancer cells. The second drug is an imm…

Matched conditions: RECURRENT GLIOSARCOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

RECURRENT GLIOSARCOMA

Get alerted when new RECURRENT GLIOSARCOMA trials appear

Scientists test 'Tiny Warhead' therapy to target deadly recurrent brain tumors